Hypolipidaemic Effects of (24R)-4α-methyl-5α-stigmasta-7,22-dien-3β-ol Derived from Aurantiochytrium mangrovei BT3 in the HEPG2 Cell Line
暂无分享,去创建一个
T. Luu | D. D. Hong | V. Chau | T. T. Nguyen | T. Hoang | H. G. Tran | T. H. T. Ngo | T. M. Nguyen
[1] Grace Guo,et al. Intake of stigmasterol and β-sitosterol alters lipid metabolism and alleviates NAFLD in mice fed a high-fat western-style diet. , 2018, Biochimica et biophysica acta. Molecular and cell biology of lipids.
[2] C. Correll,et al. The pharmacological management of metabolic syndrome , 2018, Expert review of clinical pharmacology.
[3] P. Nichols,et al. Taxonomy, ecology and biotechnological applications of thraustochytrids: A review. , 2017, Biotechnology advances.
[4] D. D. Hong,et al. Squalene promotes cholesterol homeostasis in macrophage and hepatocyte cells via activation of liver X receptor (LXR) α and β , 2017, Biotechnology Letters.
[5] Philippe Lefebvre,et al. Molecular mechanism of PPARα action and its impact on lipid metabolism, inflammation and fibrosis in non-alcoholic fatty liver disease. , 2015, Journal of hepatology.
[6] H. L. Anh,et al. Extraction of squalene as value-added product from the residual biomass of Schizochytrium mangrovei PQ6 during biodiesel producing process. , 2014, Journal of bioscience and bioengineering.
[7] R. Jiao,et al. Algal sterols are as effective as β-sitosterol in reducing plasma cholesterol concentration. , 2014, Journal of agricultural and food chemistry.
[8] D. Francis,et al. Mortality from ischaemic heart disease by country, region, and age: Statistics from World Health Organisation and United Nations , 2013, International journal of cardiology.
[9] T. Kawada,et al. Aloe vera phytosterols act as ligands for PPAR and improve the expression levels of PPAR target genes in the livers of mice with diet-induced obesity. , 2011, Obesity research & clinical practice.
[10] R. Armenta,et al. Use of raw glycerol to produce oil rich in polyunsaturated fatty acids by a thraustochytrid. , 2011, Enzyme and microbial technology.
[11] F. Blanco-Vaca,et al. New insights into the molecular actions of plant sterols and stanols in cholesterol metabolism. , 2009, Atherosclerosis.
[12] Jennifer G. Robinson,et al. Lipid-lowering effects of statins: a comparative review , 2006, Expert opinion on pharmacotherapy.
[13] T. Yanagita,et al. Campest-5-en-3-one, an oxidized derivative of campesterol, activates PPARalpha, promotes energy consumption and reduces visceral fat deposition in rats. , 2006, Biochimica et biophysica acta.
[14] C. Barrow,et al. Isolation and characterization of polyunsaturated fatty acid producing Thraustochytrium species: screening of strains and optimization of omega-3 production , 2006, Applied Microbiology and Biotechnology.
[15] S. Pal,et al. Margarine phytosterols decrease the secretion of atherogenic lipoproteins from HepG2 liver and Caco2 intestinal cells. , 2005, Atherosclerosis.
[16] S. Grundy,et al. History and development of plant sterol and stanol esters for cholesterol-lowering purposes. , 2005, The American journal of cardiology.
[17] Sander Kersten,et al. Roles of PPARs in health and disease , 2000, Nature.
[18] W. Wahli,et al. Fatty acids, eicosanoids, and hypolipidemic agents identified as ligands of peroxisome proliferator-activated receptors by coactivator-dependent receptor ligand assay. , 1997, Molecular endocrinology.
[19] T. Yokota,et al. Triterpene Alcohols and Sterols from the Fern Gleichenia japonica SPR. , 1993 .